Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

4(80.0%)

N/A

1(20.0%)

5Total

Phase 3(4)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT04641338Phase 3Completed

Fixed Combination of Dipirone and Codeine Compared to the Isolated Use of Dipyrone and Codeine in Controlling Pain After Pelvic-abdominal Surgery.

Role: collaborator

NCT05031585Not ApplicableUnknown

Efficacy and Safety Study of Nasal Lubricant Compared to Placebo on Snoring

Role: lead

NCT05110898Phase 3Unknown

Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.

Role: lead

NCT05013567Phase 3Unknown

Efficacy and Safety Study of Ibuprofen Gel Compared to Placebo in the Treatment of Acute Musculoskeletal Pain

Role: lead

NCT02735070Phase 3Unknown

Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold

Role: lead

All 5 trials loaded